Both Wegovy and Tirzepatide are powerful medications designed people control obesity, but they operate through distinct mechanisms. copyright primarily regulates glucagon-like peptide-1 (GLP-1) receptors, encouraging insulin secretion and reducing hunger . Mounjaro, however , is a double agonist that affects both GLP-1 and glucose-dependent insulin